IMMVENTION THERAPEUTIX

IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for treating inflammatory diseases. It has a platform technology where it harnesses the immune system via biodegradable biopolymeric nano/micro-particles. The company's expertise targets auto-inflammatory ailments for which there are large unmet wants, together with rheumatoid arthritis, osteoarthritis, gout, and Alzheimer’s illness. Its illness-modifying therapies inhibit irritation attributable to inflammasomes that activate inflammatory responses. The corporate makes use of its platform to find small-molecule inhibitors of a number of inflammatory receptors.

#People #Financial #Website #More

IMMVENTION THERAPEUTIX

Social Links:

Linkedin

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

2017-01-01

Address:

Chapel Hill, North Carolina, United States

Country:

United States

Website Url:

http://www.immventionthera.com

Total Employee:

11+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

7.15 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail GoDaddy DNS

Current Employees Featured

not_available_image

Anil K. Goyal
Anil K. Goyal Chairman of Board and CEO @ IMMvention Therapeutix
Chairman of Board and CEO

Founder

not_available_image

Anil K. Goyal

Investors List

north-carolina-biotechnology-center_image

North Carolina Biotechnology Center

North Carolina Biotechnology Center investment in Debt Financing - IMMvention Therapeutix

Official Site Inspections

http://www.immventionthera.com

Host Informations
Whois Informations

Loading ...

More informations about "IMMvention Therapeutix" on Search Engine